Literature DB >> 6379242

Plasma levels of proinsulin, insulin and C-peptide in chronic renal, hepatic and muscular disorders.

Y Imamura, K Yokono, K Shii, J Hari, H Sakai, S Baba.   

Abstract

Proinsulin, insulin and C-peptide levels were investigated in chronic renal, hepatic and muscular disorders. The proinsulin levels in human plasma were determined by radioimmunoassay using insulin-degrading enzyme (IDE). The fasting levels of proinsulin in 29 patients with chronic renal failure (0.95 +/- 0.05) were significantly higher than those in 10 patients with liver cirrhosis (0.46 +/- 0.04), six with muscular dystrophy (0.37 +/- 0.02) and 52 normal subjects (0.24 +/- 0.02 ng/ml, mean +/- S.E.). The fasting levels of insulin and C-peptide in chronic renal failure were also the highest among these groups. The insulin levels in liver cirrhosis and muscular dystrophy were significantly greater than those in normal subjects and increased molar ratios of proinsulin to total insulin immunoreactivity in chronic renal failure were observed. These results suggest that the kidney, liver and muscle are related to circulating insulin levels and that the kidney plays a particularly important role in circulating proinsulin levels. It can be concluded that increases in these peptides are due to a hypersecretion of B-cells, a decreased degradation or excretion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6379242     DOI: 10.2169/internalmedicine1962.23.3

Source DB:  PubMed          Journal:  Jpn J Med        ISSN: 0021-5120


  3 in total

1.  Outcomes after simultaneous pancreas and kidney transplantation and the discriminative ability of the C-peptide measurement pretransplant among type 1 and type 2 diabetes mellitus.

Authors:  H A Chakkera; J K Bodner; R L Heilman; D C Mulligan; A A Moss; K L Mekeel; M J Mazur; K Hamawi; R M Ray; G L Beck; K S Reddy
Journal:  Transplant Proc       Date:  2010-09       Impact factor: 1.066

2.  Severe anasarca due to beriberi heart disease and diabetic nephropathy.

Authors:  Jiro Toyonaga; Kohsuke Masutani; Kazuhiko Tsuruya; Naoki Haruyama; Shoichi Sugiwaka; Takaichi Suehiro; Hiroto Maeda; Masatomo Taniguchi; Ritsuko Katafuchi; Mitsuo Iida
Journal:  Clin Exp Nephrol       Date:  2009-05-22       Impact factor: 2.801

3.  Hypoglycemia Secondary to Sulfonylurea Ingestion in a Patient with End Stage Renal Disease: Results from a 72-Hour Fast.

Authors:  Alice Abraham; Mishaela Rubin; Domenico Accili; John P Bilezikian; Utpal B Pajvani
Journal:  Case Rep Endocrinol       Date:  2015-11-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.